Janet A. Jokela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Janet A. Jokela has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Amir Qaseem
American College of Physicians, Philadelphia, Pennsylvania
11 shared publications Linda L. Humphrey
Oregon Health & Science University, Portland, Oregon (L.L.H.).
11 shared publications- George M. Abraham
University of Massachusetts Medical School and Saint Vincent Hospital, Worcester, Massachusetts (G.M.A.)
9 shared publications - Jennifer Yost
M. Louise Fitzpatrick College of Nursing Villanova University Villanova Pennsylvania USA
9 shared publications - Matthew C. Miller
Penn Medicine, Philadelphia, Pennsylvania
9 shared publications - Itziar Etxeandia-Ikobaltzeta
American College of Physicians, Philadelphia, Pennsylvania
7 shared publications
Latest Publications
- 1 April 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (4) , 559-563
Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3)
The American College of Physicians (ACP) maintains living, rapid practice points on antiviral treatment in the outpatient setting for COVID-19. The Population Health and Medical Science Committee (PHMSC) developed this version 3 based on evidence from a focused update of a living, rapid review conducted by the ACP Center for Evidence Reviews at Cochrane Austria. This version addresses the SARS-CoV-2 Omicron variant and reaffirms previous practice points on the use of antiviral treatments of confirmed COVID-19 in unvaccinated or vaccinated and symptomatic patients in the outpatient setting. Consider nirmatrelvir-ritonavir combination therapy to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Do not use ivermectin to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. Do not use sotrovimab to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. The PHMSC is retiring this topic from living status considering that this update and previous surveillance have not yielded important changes to the practice points.
- 1 April 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (4) , 559-563
Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3)
The American College of Physicians (ACP) maintains living, rapid practice points on antiviral treatment in the outpatient setting for COVID-19. The Population Health and Medical Science Committee (PHMSC) developed this version 3 based on evidence from a focused update of a living, rapid review conducted by the ACP Center for Evidence Reviews at Cochrane Austria. This version addresses the SARS-CoV-2 Omicron variant and reaffirms previous practice points on the use of antiviral treatments of confirmed COVID-19 in unvaccinated or vaccinated and symptomatic patients in the outpatient setting. Consider nirmatrelvir-ritonavir combination therapy to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Do not use ivermectin to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. Do not use sotrovimab to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. The PHMSC is retiring this topic from living status considering that this update and previous surveillance have not yielded important changes to the practice points.
- Open Access
- 4 January 2026
- Published by Springer Nature in Medical Science Educator
- Vol. 36 (1) , 5-10
Generative Artificial Intelligence in Medical Training: Utilization Patterns Across Knowledge, Patient Care, Systems Reasoning, and Innovation
Since 2022, generative artificial intelligence (AI) use has grown rapidly across many sectors, including medical education. While prior research has explored perceptions of AI, the understanding of AI use amongst medical trainees has been limited. This study surveyed medical trainees to better identify the patterns of generative AI use. Results showed varying patterns based on the phase of training, with ChatGPT emerging as the predominantly used platform across all phases. While awareness of AI policies was limited, the majority reported efforts for responsible use of AI. Implications include understanding of equitable access and onboarding regarding AI use policies.
- 4 January 2026
- Published by Springer Nature in Medical Science Educator
- Vol. 36 (1) , 5-10
Open AccessGenerative Artificial Intelligence in Medical Training: Utilization Patterns Across Knowledge, Patient Care, Systems Reasoning, and Innovation
Since 2022, generative artificial intelligence (AI) use has grown rapidly across many sectors, including medical education. While prior research has explored perceptions of AI, the understanding of AI use amongst medical trainees has been limited. This study surveyed medical trainees to better identify the patterns of generative AI use. Results showed varying patterns based on the phase of training, with ChatGPT emerging as the predominantly used platform across all phases. While awareness of AI policies was limited, the majority reported efforts for responsible use of AI. Implications include understanding of equitable access and onboarding regarding AI use policies.
- 1 October 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (10) , 1396-1404
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)
Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically addressing the dominant SARS-CoV-2 Omicron variant. The Population Health and Medical Science Committee (formerly the Scientific Medical Policy Committee) developed this version of the living, rapid practice points on the basis of a living, rapid review done by the ACP Center for Evidence Reviews at Cochrane Austria at the University for Continuing Education Krems (Danube University Krems). This topic will be maintained as living and rapid by continually monitoring and assessing the impact of new evidence. Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Consider nirmatrelvir-ritonavir combination therapy to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Do not use ivermectin to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. Do not use sotrovimab to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting.
- 1 October 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (10) , 1396-1404
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)
Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically addressing the dominant SARS-CoV-2 Omicron variant. The Population Health and Medical Science Committee (formerly the Scientific Medical Policy Committee) developed this version of the living, rapid practice points on the basis of a living, rapid review done by the ACP Center for Evidence Reviews at Cochrane Austria at the University for Continuing Education Krems (Danube University Krems). This topic will be maintained as living and rapid by continually monitoring and assessing the impact of new evidence. Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Consider nirmatrelvir-ritonavir combination therapy to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Do not use ivermectin to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. Do not use sotrovimab to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting.
- 29 November 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (1) , 115-124
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)
The Scientific Medical Policy Committee of the American College of Physicians (ACP) developed living, rapid practice points to summarize the best available evidence on the treatment of adults with ... Description: Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data emerge on SARS-CoV-2 variants and the availability of newer treatments. The Scientific Medical Po...
- 29 November 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (1) , 115-124
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)
The Scientific Medical Policy Committee of the American College of Physicians (ACP) developed living, rapid practice points to summarize the best available evidence on the treatment of adults with ... Description: Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data emerge on SARS-CoV-2 variants and the availability of newer treatments. The Scientific Medical Po...
- 6 June 2022
- Published by Taylor & Francis in Teaching and Learning in Medicine
- Vol. 35 (4) , 389-397
The Use of Race, Ethnicity, and Region Associations in a USMLE Step 1 Resource
Phenomenon: Mental shortcuts are commonly used in medical education to facilitate the learning and application of a large volume of information. However, the use of demographic identifiers such as race, ethnicity, region, and descent from one of these groups as mental shortcuts in association with disease can perpetuate misconceptions about the construction of these identities and reinforce stereotypes. The United States Medical Licensing Exam (USMLE) Step 1 is a major driver of pre-clinical undergraduate medical education that requires memorization of a large volume of information and application of this information to clinical vignettes. This study assesses how demographic identifiers have been used in a nearly universally used study resource for this exam. Approach: The authors analyzed First Aid for the USMLE Step 1 2020, Thirtieth Edition, a resource that contains “high yield facts” and was built and maintained based on experiences with the USMLE Step 1 for references to race, ethnicity, region, and descent from one of these groups and the distribution of skin tones used in photos. These findings were subsequently compared to the changes made in the 2021 edition of the resource. Findings: The authors found 50 references in the 2020 edition to race, ethnicity, region, and descent from one of these groups, all in relation to disease. More than half of these references had an associated heritable component. Black or African American race was disproportionately represented, comprising more than half of all racial associations (13/24). Additionally, light skin tone was used in 170/204 photos (84.2%) in the 2020 edition. In the 2021 edition, only 12/209 photos (5.7%) were new or changed. Insights: These findings highlight the trend to associate race with disease while also furthering the misconception that there are innate, heritable differences between socially constructed groups and establishing light skin tone as the norm. While some favorable changes were made to the 2021 text, further work within this resource and across medical education is required to avoid further misuse of race and challenge existing implicit biases.
- 6 June 2022
- Published by Taylor & Francis in Teaching and Learning in Medicine
- Vol. 35 (4) , 389-397
The Use of Race, Ethnicity, and Region Associations in a USMLE Step 1 Resource
Phenomenon: Mental shortcuts are commonly used in medical education to facilitate the learning and application of a large volume of information. However, the use of demographic identifiers such as race, ethnicity, region, and descent from one of these groups as mental shortcuts in association with disease can perpetuate misconceptions about the construction of these identities and reinforce stereotypes. The United States Medical Licensing Exam (USMLE) Step 1 is a major driver of pre-clinical undergraduate medical education that requires memorization of a large volume of information and application of this information to clinical vignettes. This study assesses how demographic identifiers have been used in a nearly universally used study resource for this exam. Approach: The authors analyzed First Aid for the USMLE Step 1 2020, Thirtieth Edition, a resource that contains “high yield facts” and was built and maintained based on experiences with the USMLE Step 1 for references to race, ethnicity, region, and descent from one of these groups and the distribution of skin tones used in photos. These findings were subsequently compared to the changes made in the 2021 edition of the resource. Findings: The authors found 50 references in the 2020 edition to race, ethnicity, region, and descent from one of these groups, all in relation to disease. More than half of these references had an associated heritable component. Black or African American race was disproportionately represented, comprising more than half of all racial associations (13/24). Additionally, light skin tone was used in 170/204 photos (84.2%) in the 2020 edition. In the 2021 edition, only 12/209 photos (5.7%) were new or changed. Insights: These findings highlight the trend to associate race with disease while also furthering the misconception that there are innate, heritable differences between socially constructed groups and establishing light skin tone as the norm. While some favorable changes were made to the 2021 text, further work within this resource and across medical education is required to avoid further misuse of race and challenge existing implicit biases.
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , W116-W117
Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , W116-W117
Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
- 29 September 2021
- Published by Springer Nature in Medical Science Educator
- Vol. 31 (6) , 1957-1966
Reading and Study Habits of Medical Students on Clerkships and Performance Outcomes: a Multi-institutional Study
Purpose To describe medical students’ reading habits and resources used during clinical clerkships, and to assess whether these are associated with performance outcomes. Method Authors administered a cross-sectional survey to medical students at 3 schools midway through the clerkship year. Closed and open-ended questions focused on resources used to read and learn during the most recent clerkship, time spent and purpose for using these resources, influencers on study habits, and barriers. A multiple regression model was used to predict performance outcomes. Results Overall response rate was 53% (158/293). Students spent most of their time studying for clerkship exams and rated question banks and board review books as most useful for exam preparation. Sixty-seven percent used textbooks (including pocket-size). For patient care, online databases and pocket-sized textbooks were rated most useful. The main barrier to reading was time. Eighty percent of students ranked classmates/senior students as most influential regarding recommended resources. Hours spent reading for exams was the only significant predictor of USMLE Step 2 scores related to study habits. The predominant advice offered to future students was to read. Conclusions These findings can help inform students and educational leadership about resources students use, how they use them, and links to performance outcomes, in an effort to guide them on maximizing learning on busy clerkships. With peers being most influential, it is important not only to provide time to help students build strong reading and study habits early, but also to guide them towards reliable resources, so they will recommend useful information to others.
- 29 September 2021
- Published by Springer Nature in Medical Science Educator
- Vol. 31 (6) , 1957-1966
Reading and Study Habits of Medical Students on Clerkships and Performance Outcomes: a Multi-institutional Study
Purpose To describe medical students’ reading habits and resources used during clinical clerkships, and to assess whether these are associated with performance outcomes. Method Authors administered a cross-sectional survey to medical students at 3 schools midway through the clerkship year. Closed and open-ended questions focused on resources used to read and learn during the most recent clerkship, time spent and purpose for using these resources, influencers on study habits, and barriers. A multiple regression model was used to predict performance outcomes. Results Overall response rate was 53% (158/293). Students spent most of their time studying for clerkship exams and rated question banks and board review books as most useful for exam preparation. Sixty-seven percent used textbooks (including pocket-size). For patient care, online databases and pocket-sized textbooks were rated most useful. The main barrier to reading was time. Eighty percent of students ranked classmates/senior students as most influential regarding recommended resources. Hours spent reading for exams was the only significant predictor of USMLE Step 2 scores related to study habits. The predominant advice offered to future students was to read. Conclusions These findings can help inform students and educational leadership about resources students use, how they use them, and links to performance outcomes, in an effort to guide them on maximizing learning on busy clerkships. With peers being most influential, it is important not only to provide time to help students build strong reading and study habits early, but also to guide them towards reliable resources, so they will recommend useful information to others.
- Open Access
- 1 September 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (9) , W66-W67
Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
- 1 September 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (9) , W66-W67
Open AccessUpdate Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
- Open Access
- 1 August 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (8) , 1126-1132
The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians
In response to the COVID-19 pandemic, the American College of Physicians' Scientific Medical Policy Committee began developing “practice points” to provide clinical advice based on the best availab... In response to the COVID-19 pandemic, the Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) began developing “practice points” to provide clinical advice based ...
- 1 August 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (8) , 1126-1132
Open AccessThe Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians
In response to the COVID-19 pandemic, the American College of Physicians' Scientific Medical Policy Committee began developing “practice points” to provide clinical advice based on the best availab... In response to the COVID-19 pandemic, the Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) began developing “practice points” to provide clinical advice based ...